REQUEST A DEMO
Total
USD $0.00
Search more companies

Limedika UAB (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Limedika UAB Profile Updated: November 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

JSC Limedika is a pharmaceutical company that operates a logistics center and warehouses, supplying pharmacies and hospitals with a wide range of medications, including pharmaceuticals, dietary supplements, surgical products, rehabilitation equipment, herbs, pregnancy and baby items, and cosmetics. The company also provides marketing services and has developed a separate activity in the distribution of veterinary medications and animal care products. JSC Limedika represents over 250 manufacturers of medicines and food supplements and was the first wholesale pharmaceutical company to be listed on the Officially Approved Suppliers List in 2007.

Headquarters
Karmelavos sen. Ramuciu k. Erdves g. 2
Kaunas; Kaunas County; Postal Code: LT-52114

Contact Details: Purchase the Limedika UAB report to view the information.

Website: http://www.limedika.lt

Basic Information
Total Employees:
Purchase the Limedika UAB report to view the information.
Outstanding Shares:
Purchase the Limedika UAB report to view the information.
Registered Capital:
Purchase the Limedika UAB report to view the information.
Incorporation Date:
April 29, 1994
Key Executives
Purchase this report to view the information.
General Director
Company Performance
Financial values in the chart are available after Limedika UAB report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
11.56%
Total operating revenue
11.56%
Net Profit (Loss) for the Period
13.83%
Total equity
9.24%
Net Profit Margin
0.04%
Return on Equity (ROE)
3.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?